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Background: Recent evidence suggests that persistent pain and recurrent pain are due to the pain memory which
is related to the phosphorylation of cAMP response element-binding protein (p-CREB) in anterior cingulate cortex
(ACC). Eletroacupuncture (EA), as a complementary Chinese medical procedure, has a significant impact on the
treatment of pain and is now considered as a mind-body therapy.
Methods: The rat model of pain memory was induced by two injections of carrageenan into the paws, which was
administered separately by a 14-day interval, and treated with EA therapy. The paw withdrawal thresholds (PWTs) of
animals were measured and p-CREB expressions in ACC were detected by using immunofluorescence (IF) and
electrophoretic mobility shift assay (EMSA). Statistical comparisons among different groups were made by one-way,
repeated-measures analysis of variance (ANOVA).
Results: The second injection of carrageenan caused the decrease of PWTs in the non-injected hind paw. EA
stimulation applied prior to the second injection, increased the values of PWTs. In ACC, the numbers of p-CREB
positive cells were significantly increased in pain memory model rats, which were significantly reduced by EA.
EMSA results showed EA also down-regulated the combining capacity of p-CREB with its DNA. Furthermore, the
co-expression of p-CREB with GFAP, OX-42, or NeuN in ACC was strengthened in the pain memory model rats. EA
inhibited the co-expression of p-CREB with GFAP or OX-42, but not NeuN in ACC.
Conclusions: The present results suggest the retrieval of pain memory could be alleviated by the pre-treatment of
EA, which is at least partially attributed to the down-regulated expression and combining capacity of p-CREB and
the decreased expression of p-CREB in astrocytes and microglia cells.
Keywords: Electroacupuncture, Pain memory, Phosphorylation of cAMP response elment-binding protein, Anterior
cingulate cortex, RatBackground
Persistent pain caused by inflammation, surgical wounds,
and other injuries is a very common phenomenon. Pa-
tients who suffer from nociceptive pain for a long time
may feel persistent pain even after recovery of the initial
cause of pain [1,2]. Animal studies also reported that noci-
ceptive hyperalgesia could recur far away from the* Correspondence: fangjianqiao7532@163.com
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unless otherwise stated.primary injured region after repeated carrageen-induced
inflammation [3]. Recent researches indicated the pain
memory was a key mechanism of this special pain. The
initial memory of the pain can be accentuated by the emo-
tional component of reliving its memory, resulting in a
more vivid and stronger memory of the pain [4]. The pain
syndrome, due to synaptic plasticity changes in the central
nervous system, existed after the recovery of primary in-
flammation [5]. So it has been suggested that if pain mem-
ory itself is a primary etiology of persistent pain, how tois is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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algesia for prolonged pain.
Which part of the brain participates in this “pain
memory”? Evidence suggests that the anterior cingulate
cortex (ACC), the insular cortex, and the amygdala are
examples of regions implicated in both pain and mem-
ory [4]. The ACC is an important site for cortical regula-
tion of nociception and persistent pain after amputation
[6]. Furthermore, based on functional magnetic reson-
ance imaging (fMRI) studies in both rats and humans,
the ACC is involved in pain memory processing [7,8].
The transcription factor cAMP response element-
binding protein (CREB) plays an important role in learn-
ing and memory. Evidence from aplysia, drosophila, mice,
and rats all showed that CREB-dependent transcription
was required for the cellular events underlying long-term
memory, especially the late phase of long-term potenti-
ation (LTP) [9-11]. A variety of neuron types,especially the
neurons and astrocytes, are able to activate CREB to par-
ticipate in the formation of synaptic plasticity in the cen-
tral nervous system and the regulation of physiological
and pathological processes [12,13]. The phosphorylation
of CREB is directly related to the process of acquisition,
consolidation, and retrieval of pain memory [14,15].
Electroacupuncture (EA), a widely used Chinese med-
ical therapy, is a modified form of acupuncture that uses
electrical stimulation. Several studies have investigated
the effectiveness of EA on pain induced by inflammation
[16-19]. EA has also been proven to enhance the function
of cognition, learning, and memory in animal models of
ischemic injury, vascular dementia, and Alzheimer’s dis-
ease [20-23]. Some researchers support the notion that
acupuncture is a mind-body therapy that helps to reinte-
grate important neural dimensions of inner life and to es-
tablish psychophysical pain homeostasis [24]. However,
few studies have investigated whether EA stimulation is
effective for pain memory and elucidated the underlying
mechanisms of this treatment.
Therefore, in the present study, we aimed to deter-
mine whether EA could ameliorate pain memory by
regulating the expression and combining capacity of
phosphorylation of CREB (p-CREB) as well as the co-




Thirty male adult Sprague–Dawley rats (Sino-British
SIPPR/BK Lab. Animal Ltd., Shanghai, China) weighting
180–200 g (6 weeks) were group housed for every five
rats per cage in a controlled room temperature (22°C)
and kept on a 12 h light–dark cycle with free access to
rodent chow and water. The total number of rats was
calculated by the estimation of sample size based oncomparing multiple samples mean with the power of
95%. At least 6 rats were needed in each group revealed
by the calculated results. To reduce the results error, the
final sample size was determined 10 rats of each group.
Thirty rats were randomly divided into 3 groups (n = 10
each): control group, model group and EA group. From
each group, ten rats were all used for the detection of
paw withdrawal thresholds (PWTs). Three of 10 rats
were further used for the determination of p-CREB com-
binative activity in ACC by electrophoretic mobility shift
assay (EMSA), while seven others were used for the meas-
urement of expression of p-CREB in nerve cells of ACC by
immunofluorescence (IF). All animal experiments were
performed according to the National Institutions of Health
Guide for the Care and Use of Laboratory Animals [17].
Establishment of pain memory model
We used the model of pain memory described by Igor
Kissin [3], in which inflammation was induced by two
injections of carrageenan. The first inflammation was
induced by subcutaneous injection (0.5 mm diameter ×
20 mm long needle) of 0.1 mL of 2% carrageenan (Sigma
Chemical Co, St. Louis, MO, USA) into the plantar sur-
face of the right hind paw. The plantar surface of the
rat’s left hind paw was injected 14 days after the first in-
jection to the right hind paw, giving rise to the second
inflammation.
The response to noxious pressure was determined by
measuring paw mechanical withdrawal thresholds. Noci-
ceptive memory regarding secondary hyperalgesia was
assessed by measuring distant hyperalgesia, in which the
previously injected hind paw (right) didn’t receive an-
other injection when repeated carrageenan-induced in-
flammation was made in the left hind paw. Therefore,
the right hind paw and left ACC of rats were used for
the detection of pain memory in this study.
EA treatment procedures
The rats of the EA group were administrated electroacu-
puncture stimulation as previously described [17,25].
The treatment was given at 5 h (after the behavioral
test), 23 h (before the behavioral test), 47 h (before the
behavioral test), and 71 h (before the behavioral test)
after the first carrageenan-injection for 30 min per treat-
ment. The stainless acupuncture needles (0.3 mm in
diameter × 13 mm in length) and HANS Acupuncture
Point Nerve Stimulator (LH-202H; Huawei Co., Ltd.,
Beijing, China) were applied at bilateral acupoints “Zusanli”
(ST36, 7 mm lateral to the anterior tubercle of the tibia)
and the reference electrode was fixed at 1 cm inferior
“Zusanli” in rats. The parameters of EA were set as follows:
2/100 Hz of frequency with automatically shifting between
2 Hz and 100 Hz stimulation for 3 s each; a square wave
current output (pulse width: 0.2 ms); an intensity range of
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tions. The EA administration and other managements
were conducted by an acupuncture specialist. Animals
were calmed by placing the heads in black hoods with no
physical restraint. No sign of stress, such as increased
urination or defecation, was observed. At the same time,
the rats of both model and control groups also received
the same administration to maintain consistency.
Behavioral test procedures
The PWTs were the nociceptive test used to provide be-
havioral evidence in this study. The response to noxious
pressure was detected by UGO-Basile Dynamic Plantar
Aesthesiometer (UGO 37450, Milan, Italy). Ten rats of
each group were included to assess the pain situation
and were measured at 4 h, 24 h, 48 h, and 72 h after the
different two injections. As described before [26,27], rats
were placed on a metal mesh table and in an individual
plexiglass housing designed to provide adequate comfort
and ventilation for 30 min to adapt to the environment
prior to starting experimental manipulations. A steel rod
(0.5 mm diameter) was pushed up to the plantar surface
of the hind paw with increasing force (2.5 g/s). The cut-
off pressure was 50 g. The thresholds were recorded when
the rat struggled with increasing pressure or reached the
cutoff pressure. Five measurements were taken at 5-min
intervals, and the last four were averaged. To reduce the
stressful stimulation of environments, all behavioral tests
were done between 9:00 and 15:00 by the same investiga-
tor, and the rats were habituated to the testing procedures
and environments 2 days before the experiment. The in-
vestigator was blind to the rats’ allocation in grouping.
Electrophoretic mobility shift assay procedures
Nuclear proteins for EMSA were extracted using the
Nuclear and Cytoplasmic Extraction Kit (Beyotime,
Shanghai, China). Sequences corresponding to the CRE-
binding site labeled with biotin (synthesized and 3’
labeled by Sangon Inc., Shanghai, China) of oligonucleo-
tide probes were as follows: 5’-AGA GAT TGC CTG
ACG TCA GAG AGC TAG-3’ and 5’-CTA GCT CTC
TGA CGT CAG GCA ATC TCT-3’. To determine the
specificity of the binding complexes of the proteins of p-
CREB and its DNA, reactions that using unlabeled
probes and unlabeled mutational probes were performed
competitively. The sequences of unlabeled p-CREB
probes were as the same as biotin-labeled p-CREB
probes while unlabeled mutational probes’ sequences
were 5’-AGA GAT TGC CTG TGG TCA GAG AGC
TAG-3’ and 5’-CTA GCT CTC TGA CCA CAG GCA
ATC TCT-3’.
EMSA was performed by using the Light Shift Kit
(Pierce, Thermo, Rockford, IL, USA). According to the
protocols of the kit, the binding reaction was carried outin a total volume of 20 mL containing ultrapure water,
10× binding buffer, 1 μg/μL Poly (dl•dc), 50% glycerol,
1% NP-40, 100 mM MgCl2, unlabeled p-CREB probes/
unlabeled mutational p-CREB probes, protein extract
(15 μg/lane), and biotin-labeled p-CREB probes. Samples
were incubated on ice for 50 min, and mixed with 5×
loading buffer subsequently. The complexes of protein
and oligonucleotide probes were loaded in a native 6%
polyacrylamide gel and run in 0.5× TBE buffer, 100 V
for 1 h, then transferred onto a positively charged nylon
membrane at 380 mA for 30 min. After the membrane
was crosslinked, we proceeded directly to detection by
Chemiluminescent Nucleic Acid Detection Module (Pierce,
Thermo, Rockford, IL, USA). For competitive experiments,
the unlabeled competitive probes which were 50-fold excess
to the labeled probes were pre-incubated for 20 min.
Double-immunofluorescence labeling procedures
Left ACC of rats’ brain in each group used for IF was
fixed and post-fixed in 4% paraformaldehyde (pH 7.3),
dehydrated in 15–30% gradient sucrose and frozen
at −80°C. Coronal brain slices containing the ACC
were cut at 30 μm on a cryostat microtome (Microm
HM 550; Thermo). Sections at the level of bregma
3.2 mm were chosen from the bregma 3.2 mm, 2.7 mm,
and 2.2 mm by preliminary experiments. According to the
double-immunofluorescence labeling procedures [18,21],
coronal brain slices were washed with 0.01 M PB saline
(PBS, pH 7.4) for 2 × 5 min and blocked with 5% goat
serum in PBS for 1 h at 37°C. The sections were then
incubated overnight at 4°C with an anti-phospho-
CREB (Ser133) polyclonal antibody (rabbit-anti, 1:1000;
Millipore, Billerica, MA, USA) and either an anti-GFAP
monoclonal antibody (mouse-anti, 1:100; Abcam, Boston,
MA, USA), an anti-FOX3/NeuN monoclonal antibody
(mouse-anti, 1:1000; Abcam), or a CD11b monoclonal
antibody (mouse-anti, 1:100; AbDSerotec, Oxford, UK).
After 3 × 10 min rinses in PBS, the sections were incu-
bated in a Cy3-conjugated secondary antibody (goat anti-
rabbit, 1:1000, Jackson ImmunoLabs, West Grove, PA,
USA) and an Alexa Fluor 488-conjugated secondary anti-
body (goat anti-mouse, 1:200; Jackson ImmunoLabs). Fi-
nally, the slides were examined with a Nikon A1R laser
scanning confocal microscope and the positive cells were
counted with NIS elements AR software, which is
equipped for Nikon DS series digital cameras in laser con-
focal microscope to control microscope and capture
microscopic image. This software is also used for im-
munofluorescence data analysis.
Statistical analysis
Statistical comparisons among different groups were
made by one-way, repeated-measures analysis of vari-
ance (ANOVA). For the following multiple comparisons,
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test were used for equal variances assumed or not as-
sumed respectively, as examined by the homogeneity of
variance test. Data were expressed as means ± SEM. Sig-
nificance was determined at the level of P < 0.05.
Results
EA intervened in the mechanical allodynia in the pain
memory model
We used the rat model of pain memory described by
Igor Kissin [3]. Following the model establishment and
testing of mechanical allodynia (Figure 1), we investi-
gated the changes in PWTs after two carrageenan injec-
tions separated by a 14-day interval. At 4 h after the first
injection of carrageenan, the injected hind paw showed a
profound decrease in noxious withdrawal thresholds
compared with the control group (P < 0.01), keepingFigure 1 Mechanical allodynia of rats in repetitive-crossover carragee
tested for mechanical allodynia of bilateral hind paws at time points of bef
injection was administered into the plantar surface of the right paw (a and
later (c and d). The results showed a sustained decrease of mechanical thr
of the mean. Ten rats for each group. ** p < 0.01, vs. the control group; # pdecrease until 72 h. While EA intervention, adminis-
trated at 5 h after carrageenan injection and for continu-
ous 4 treatments with 24 h interval, increased the pain
threshold at hours of 24, 48 and 72, compared with the
model group (P < 0.01) (Figure 1a). No significant
changes in PWTs at the observed times were found on
the non-injected hind paw (Figure 1b).
Fourteen days after the pain withdrawal thresholds
had returned to its baseline, the second injection of carra-
geenan to the previously non-injected hind paw caused a
similar decrease of PWTs in the left hind paw from 4 h to
72 h. The pre-administration of EA did not produce any
change in PWTs compared with the model group at any
time point (Figure 1c). While in the right hind paw, the
one previously injected and non-injected twice, PWTs in
the model rats did not obviously change at 4 h, but
were decreased from the baseline of 27.68 ± 0.97 g tonan injection with a 2-week interval. Rats of each group were
ore (Base), and 4 h, 24 h, 48 h, 72 h after carrageenan-injection. The first
b); the second injection was administered into the left paw 2 weeks
eshold in the initial injected paw (d). Error bars indicated standard error
< 0.05, ## p < 0.01, vs. the model group.
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at 48 h and 19.51 ± 1.36 g (P < 0.01) at 72 h (Figure 1d). At
the same time, compared with the model group, EA
intervention kept higher PWTs at 24 h (P < 0.01) and
48 h (P < 0.05), sharing similar level in PWTs with the
control group. The PWTs at 72 h were decreased in EA
group compared with the control group (P < 0.05), but it
still showed higher than that in the model group (P < 0.05).
The PWTs at 24 h, 48 h and 72 h in control group showed
no difference compared with its baseline.
EA reduced the phosphorylation level of CREB in ACC
CREB is one of the most important nuclear transcription
factors involved in regulating memory function. We
tested the activation of p-CREB in the ACC of the pain
memory model with IF and EMSA. Figures 2 and 3
showed the results separately. The left ACC, which
reflected the change of original injected paw (right) [28],
was chosen for testing. Numbers of p-CREB positiveFigure 2 Phosphorylation of CREB in the anterior cingulate cortex (AC
were presented in figure a, b, and c. Yellow line in figure a indicated the s
counted. The left ACC in the harvested brain cortex was circled with a yello
in figure e. Error bars indicated standard error of the mean. Three rats for e
## p < 0.01, vs. the model group.cells were increased in the rats of model group com-
pared with those in the control group (P < 0.01). In the
EA group, the positive cells of p-CREB were more than
those in the control group (P < 0.01), but less than those
in the model group (P < 0.01).
EMSA performed with a CRE-containing oligonucleo-
tide revealed different binding complexes attributed to
electrophoretic mobility. The binding complexes observed
in the polyacrylamide gel were of specific sequence because
the retarded bandings were lost when the 50× unlabeled p-
CREB probes and 50× unlabeled mutational p-CREB
probes were used (Figure 3a). EMSA was performed by
using the p-CREB proteins with biotin-labeled probes that
containing p-CREB DNA among different groups. The ob-
served binding complexes showed different combining cap-
acities of p-CREB among the control, model, and EA
groups. The band of model group was much stronger than
that of control group, while EA attenuated the band as
compared with model group (Figure 3b).C). Differences in p-CREB expressions in control, model, and EA groups
elected field in which the numbers of p-CREB-positive cells were
w line in figure d. Quantification of p-CREB positive cells was shown
ach group, five slides for each rat. ** p < 0.01, vs. the control group;
Figure 3 Binding activity of p-CREB in nuclear extracts assessed by EMSA. The part a showed the excess of unlabeled p-CREB probes and
unlabeled mutational p-CREB probes abolished binding, demonstrating the specificity of all binding complexes. Binding activity of p-CREB among
the control, model, and EA groups was shown in the part b. Arrows indicated the binding of p-CREB and the free probe.
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memory model and the declining of co-localizations of
p-CREB with GFAP, OX-42, but not NeuN in ACC by EA
To further clarify the localization of p-CREB in ACC
after formation of pain memory and cellular targets of
EA treatment, we examined the activations of astro-
cytes (GFAP), microglia (OX-42) and neurons (NeuN)
as well as the co-localizations of p-CREB in these cell
types in ACC.
The results from IF showed a substantial increase in
the number of GFAP-positive cells after retrieval of
pain memory, compared with that in the control
group (P < 0.05). EA treatment produced no obvious
decrease of GFAP-positive cells in ACC compared
with the model group (Figure 4a, c). The double
immunofluorescence examinations showed remark-
ably increased numbers of GFAP-positive cells co-
expressing p-CREB in the model group, compared
with those in the control group (P < 0.01). In contrast
to the lack of changes in GFAP immunostaining after
EA intervention, the decreased numbers of GFAP-
positive cells co-expressing p-CREB were observed,
compared to those in the model group (P < 0.01)
(Figure 4b, d).Similar to GFAP, the increase in the number of OX-
42-positive cells in ACC was observed both in the model
group and EA group, compared with that in the control
group (P < 0.05, Figure 5a, c). The double immunofluor-
escence showed the increased numbers of OX-42-
positive cells co-expressing p-CREB in the model group
(P < 0.05), and there was no obvious increase in co-
localizations of p-CREB and OX-42 in EA group
(Figure 5b, d), compared with those in the control
group.
Compared with the control group, the number of
NeuN-positive cells did not change in the model and EA
groups, while the number of NeuN and p-CREB
double-labeled cells increased significantly in both
groups (P < 0.05, Figure 6a, c). EA group did not show
any difference in NeuN and p-CREB co-localizations
with the model group (Figure 6b, d).
Discussion
In this study, we presented inspiring outcomes: (1) Pain
memory occurred in model rats after the second carra-
geenan injection; (2) The EA treatment not only allevi-
ated the initial pain induced by carrageenan injection,
but also delayed the awaken time of pain memory and
Figure 4 Co-localization of p-CREB and GFAP in coronal brain sections of ACC. Photomicrographs showed the expression of p-CREB (red)
and GFAP (an astrocytic marker, green) from the same sections in figure a. Figure b was a high magnification image of the areas indicated by the
yellow squares in the figure a. The double-immunofluorescence labeling showed that p-CREB co-expressed with GFAP in the ACC. Numbers of
GFAP-positive cells and co-localization of p-CREB with GFAP were analysed in figure c and d. Error bars indicated standard error of the mean. Four
rats for each group, five slides for each rat. * p < 0.05, ** p < 0.01 vs. the control group; ## p < 0.01 vs. the model group.
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expression and ability of combination of p-CREB in
ACC, inhibiting the retrieval of pain memory; (4) EA
contributed to the decrease of the expression of p-CREB
in the astrocytes and microglia cells, but not in the neu-
rons, impacting the pain memory.
EA alleviated pain by intervening in the retrieval of pain
memory
Memory is a key variable for pain management [29]. The
process of pain memory consists of acquisition, consoli-
dation and retrieval [14,30-32]. Nociceptive stimulation
acquired and transferred to related cortex becomes along-term memory that is manifested in the increase of
protein synthesis, changes of synaptic structure and
function [28,33]. More importantly, expectation of pain
established and consolidated through associative learning
can lead to affective responses similar to those evoked by
acute pain, as well as coping responses that modulate sub-
sequent pain perception [34]. The Dr. Kissin’s experiment
demonstrated that after recovery of hyperalgesia induced
by the initial carrageenan-induced inflammation, repeated
inflammation led to the development of a distant hyper-
algesia that was absent during the initial inflammation [3].
In this study, we found that the second carrageenan injec-
tion did not only induce the similar acute inflammation
Figure 5 Co-localization of p-CREB and OX-42 in coronal brain sections of ACC. Photomicrographs showed the expression of p-CREB (red)
and OX-42 (a microglial marker, green) from the same sections in figure a. Figure b was a high magnification image of the areas indicated by the
yellow squares in the figure a. The double-immunofluorescence labeling showed that p-CREB co-expressed with OX-42 in the ACC. Numbers of
OX-42-positive cells and co-localization of p-CREB with OX-42 were analysed in figure c and d. Error bars indicated standard error of the mean.
Four rats for each group, five slides for each rat. * p < 0.05 vs. the control group.
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sia in the previously-injected but non-post-injected hind
paw from 24 h to 72 h after the second injection into the
opposite hind paw. It evidences that the pain memory oc-
curred successfully by carrageenan-injection twice. The
acute inflammation pain following a single injection of
carrageenan in rat’s hind paw of one side would be the
process of acquisition the pain information, and trans-
forms gradually into long-term memory which is consoli-
dated by other environmental stimulations and factors.
At the same time, the EA treatment postponed the
awaken time of pain memory to 72 h after injection and
reduced the intensity of pain as compared to modelgroup. However, the pre-administration of EA had no
influence on the acute inflammatory pain caused by
carrageenan-injection twice in the left hind paw. This
suspects the possibility that different interventional
mechanism is existed between pain memory and pain
perception by EA.
ACC took part in the pain memory by regulating the level
of p-CREB
Several lines of evidence have implicated the critical role
of ACC in the formation of pain memory. Electrophysio-
logical recordings from ACC neurons in animals showed
that ACC cells responded to peripheral noxious stimuli
Figure 6 Co-localization of p-CREB and NeuN in coronal brain sections of ACC. Photomicrographs showed the expression of p-CREB (red)
and NeuN (a neuronal marker, green) from the same sections in figure a. Figure b was a high magnification image of the areas indicated by the
yellow squares in the figure a. The double-immunofluorescence labeling showed that p-CREB co-expressed with NeuN in the ACC. Numbers of
NeuN-positive cells and co-localization of p-CREB with NeuN were analysed in figure c and d. Error bars indicated standard error of the mean.
Four rats for each group, five slides for each rat. * p < 0.05 vs. the control group.
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confirmed that the ACC, together with other cortical
structures, were activated by acute noxious stimuli, psy-
chological pain, and social pain [36,37]. The ACC was
also considered as a pivotal region for emotion that in-
volves events, memories, and association with auto-
nomic changes. Perigenul ACC activation was involved
in long-term negative affective state and prediction of
aversive stimuli by contextual cue for the memory pro-
cessing [8]. There exists strong evidence that long-term
changes in the ACC contributed to chronic pain-
induced cognitive and emotional impairment assessed by
using behavioral test and electrophysiological approachesin mice [13,38]. Therefore, ACC is a nucleus in brain that
is closely related to pain and pain memory.
The pain itself was closely related to CREB activation
and the interrelation between them can be effectively in-
tervened by EA therapy [39]. More importantly, CREB
plays a central role in the formation of long-term mem-
ory [40-42]. Various reports demonstrate that the con-
nection of CREB and long-term memory is definite. The
researches reported that the induction of a dominant-
negative mutation or the deletion of key CREB isoforms
blocked long-term memory [11,43]. And the increased
level of p-CREB at Ser-133 resulted in the synaptic plas-
ticity in the process of learning and memory [44,45].
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that the expression of certain genes through phosphoryl-
ation of CREB is required to maintain the late phase of
long-term potentiation and long-term memory [46,47].
Together with all mentioned above, recent studies have
shown that both ACC and p-CREB played an important
role in pain and its memory. That is why we have chosen
both of them for exploring the effect and its mechanism
of EA treatment in intervening pain memory.
EA down-regulated the expression and activity of
combination of p-CREB in ACC to inhibit the retrieval
of pain memory
The results of this research indicated that phosphoryl-
ation of CREB increased significantly, and could be ef-
fectively inhibited by EA treatment. The other studies
demonstrated that disruption of CREB function impaired
both memory for objects and memory for spatial loca-
tion of objects after a 24 h delay [12,48]. In the adult rat,
CREB is normally abundant in its non-phosphorylated
state. When its upstream signaling kinases are activated
in response to environmental stimulations and factors
such as stress, mitogens, and excitatory signals including
calcium, CREB becomes phosphorylated [49,50]. Mean-
while, the increased expression of p-CREB is a manifest-
ation of the formation of memory in the cerebral cortex
in rodents [51]. Therefore, it is a memory of pain that
aggravates the response to pain caused by phosphoryl-
ation of CREB, and the EA treatment in the study may
act as an analgesic by decreasing p-CREB.
When CREB is phosphorylated at Ser 133, it promotes
the transcription of genes by interacting with the CRE se-
quence located in the promotor regions (TGACGTCA)
[52-54]. The EMSA indicated the ability of this combin-
ation. In experiment’s results, the amount of DNA-protein
complex was gradually increased in the rats of the pain
memory model. However, p-CREB binding was decreased
in the rats of EA group. This revealed that EA could lower
the level of activated combination between p-CREB pro-
tein and its DNA. Other research suggested that the key
steps involved in CREB-mediated gene transcription in-
cluded dimerization, binding at response elements in
DNA, and phosphorylation [43]. By using immunoelec-
tronmicroscopy, immunoblotting, and electrophoretic
mobility shift assays, Cammarota et al. strongly suggested
that the activation of nuclear CREB might be related to
the up-regulation of transcription during memory for-
mation [55,56]. Some other reports also determined that
p-CREB isolated from cultured cells could bind to an
oligonucleotide identical in sequence to the CART gene
promoter CRE cis-regulatory element in EMSA/super
shift analyses [57,58]. These results suggested distinctly
that memory of pain was generated in response to the
improved ability of an activated combination betweenp-CREB protein and its DNA. On the contrary, EA
treatment could inhibit it to partially block the memory
of pain. This indicates that EA treatment is able to
intervene in the combining capacity of p-CREB protein
and CRE-containing oligonucleotide. Above results of
p-CREB in ACC suggests that EA treatment has a posi-
tive mechanism of its effect on pain memory.
EA intervened in the expression of p-CREB in the
astrocytes and microglia cells in ACC to impact
the pain memory
To distinguish the target nerve cells in the ACC that
participated in the effect of EA on pain memory in rats,
we observed the expression of p-CREB in neurons
(NeuN) and gliocyte which including astrocytes (GFAP)
and microglia (OX-42) by double-immunofluorescence la-
beling. The results showed that EA intervened in the ex-
pression of p-CREB in the astrocytes and microglia, but
not in the neurons in ACC of the pain memory model.
Relevant studies demonstrated that activation of astro-
cytes in the ACC contributed to the affective component
of pain [59]. Other research confirmed that in the condi-
tion of inflammatory pain, astrocytes were converted to
an activated state and amplified the magnitude of LTP
[13], and that LTP in the ACC was a mechanism for per-
sistent affective changes in patients with chronic pain
[60]. Our results showed the consistency with previous
researches. We found in the model of pain memory, as-
trocytes could be activated because of the retrieval of
pain memory. At the same time, the increase of the ex-
pression of p-CREB in the astrocytes of model group
was significant and EA could inhibit this trend. EA treat-
ment significantly declined the expression of p-CREB in
astrocytes. This indicates EA might inhibit pain-induced
central sensitization, via intervening in the activation of
p-CREB in astrocytes, which is resulted in a reduction in
the development of pain memory.
Few studies have investigated whether microglia are
involved in pain sensitization above the spinal cord.
However, in the development and maintenance of the
chronic pain state, microglia may be activated without
any changes in obvious morphological or staining charac-
teristics, which have previously been used to characterize
the resting-to-activated transition. It appears that even in
the resting state, microglia is functionally active [61]. The
results of this study demonstrate the numbers of p-CREB
expressed in microglia were increased obviously in the
ACC and EA therapy had a tendency to inhibit.
It is well accepted that neuron and glia always interact
together in brain functions and neurological disorders
including chronic pain [62-64]. By using electrophysio-
logical approaches, the study provided strong evidence for
long-term changes of temporal precision of information
coding in cortical neurons after peripheral injuries and
Sun et al. Behavioral and Brain Functions  (2015) 11:9 Page 11 of 12explained neuronal mechanism for chronic pain caused
cognitive and emotional impairment [38]. In this study,
though the number of neurons in three groups didn’t
show the difference, the expression of p-CREB in neuron
increased in the model group. It demonstrated that p-
CREB expressed in neuron had participated in the process
of pain memory. EMSA result also suggested the decline
of activity of p-CREB owned to the EA intervention.
So it could be inferred that EA might intervene in the
pain memory in neuron by declining the activity of
combination of p-CREB, without affecting the expres-
sion of p-CREB in neurons. Moreover, that whether
there are other factors or signaling pathways exchanges in
neurons of pain memory, needs to be explored in the fu-
ture. Besides, astrocytes outnumbered neurons and were
closely associated with neurons [65]. More researches
must be done to find whether or not neurons interact with
astrocytes or microglia and the mechanism of EA inter-
vention is possibly related to the change in neurons.
Conclusions
In conclusion, the present study demonstrates that
inflammation-induced pain memory could be indeed
caused by repeated injections of inflammatory mediators
in rats. EA stimulation is able to influence pain memory
by delaying its awaken time and reducing the intensity
of pain. The pain memory and its retrieval are most
likely related to the increase of p-CREB in ACC. The
possible mechanism of EA on alleviating pain memory is
at least partially related to the inhibition of the expres-
sion of p-CREB in astrocytes and microglia in ACC.
Therefore, EA treatment might be a potential pathway
of intervention in the induction and development of
pain memory.
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